Homozygote TH-MYCN+/+ transgenic mice develop neuroblastoma in paravertebral and coeliac ganglia with most of the features of the human disease at postnatal 6–7 weeks in 100% of mice [20]. Here, MYCN is linked to neuroblastoma.